vs
Bioceres Crop Solutions Corp.（BIOX）与N2OFF, Inc.（NITO）财务数据对比。点击上方公司名可切换其他公司
Bioceres Crop Solutions Corp.的季度营收约是N2OFF, Inc.的38798.3倍（$77.6M vs $2.0K）。N2OFF, Inc.净利率更高（21450.0% vs -9.6%，领先21459.6%）。Bioceres Crop Solutions Corp.同比增速更快（-16.8% vs -77.8%）。过去两年Bioceres Crop Solutions Corp.的营收复合增速更高（-8.4% vs -86.2%）
Bioceres Crop Solutions Corp是一家全球农业科技企业，研发并商业化耐旱种子性状、生物肥料、生物农药等可持续作物增产解决方案，服务南美、北美、欧洲及亚太地区的农户，致力于提升作物产量，同时降低农业生产的环境影响。
BIOX vs NITO — 直观对比
营收规模更大
BIOX
是对方的38798.3倍
$2.0K
营收增速更快
BIOX
高出61.0%
-77.8%
净利率更高
NITO
高出21459.6%
-9.6%
两年增速更快
BIOX
近两年复合增速
-86.2%
损益表 — Q1 2026 vs Q3 2025
| 指标 | | |
|---|---|---|
| 营收 | $77.6M | $2.0K |
| 净利润 | $-7.4M | $429.0K |
| 毛利率 | 46.8% | — |
| 营业利润率 | 9.3% | -66300.0% |
| 净利率 | -9.6% | 21450.0% |
| 营收同比 | -16.8% | -77.8% |
| 净利润同比 | -20.2% | 118.9% |
| 每股收益（稀释后） | $-0.12 | $0.97 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BIOXNITO
| Q3 25 | $77.6M | $2.0K | ||
| Q2 25 | — | $0 | ||
| Q1 25 | $60.6M | $66.0K | ||
| Q4 24 | $98.8M | $140.0K | ||
| Q3 24 | $93.3M | $9.0K | ||
| Q2 24 | — | $17.0K | ||
| Q1 24 | $84.0M | $44.0K | ||
| Q4 23 | $140.2M | $105.4K |
净利润BIOXNITO
| Q3 25 | $-7.4M | $429.0K | ||
| Q2 25 | — | $-4.5M | ||
| Q1 25 | $-1.6M | $-1.2M | ||
| Q4 24 | $605.2K | $-1.4M | ||
| Q3 24 | $-6.2M | $-2.3M | ||
| Q2 24 | — | $-787.0K | ||
| Q1 24 | $9.8M | $-769.0K | ||
| Q4 23 | $1.2M | $-1.7M |
毛利率BIOXNITO
| Q3 25 | 46.8% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 39.4% | 78.8% | ||
| Q4 24 | 42.0% | 61.4% | ||
| Q3 24 | 40.2% | -755.6% | ||
| Q2 24 | — | 64.7% | ||
| Q1 24 | 50.8% | 36.4% | ||
| Q4 23 | 36.7% | — |
营业利润率BIOXNITO
| Q3 25 | 9.3% | -66300.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.5% | -937.9% | ||
| Q4 24 | 14.5% | -72.1% | ||
| Q3 24 | 2.5% | -15955.6% | ||
| Q2 24 | — | -4982.4% | ||
| Q1 24 | 15.7% | -2043.2% | ||
| Q4 23 | 12.0% | -2028.0% |
净利率BIOXNITO
| Q3 25 | -9.6% | 21450.0% | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.6% | -1807.6% | ||
| Q4 24 | 0.6% | -980.7% | ||
| Q3 24 | -6.6% | -25155.6% | ||
| Q2 24 | — | -4629.4% | ||
| Q1 24 | 11.6% | -1747.7% | ||
| Q4 23 | 0.9% | -1644.7% |
每股收益（稀释后）BIOXNITO
| Q3 25 | $-0.12 | $0.97 | ||
| Q2 25 | — | $-0.18 | ||
| Q1 25 | $-0.02 | $-0.39 | ||
| Q4 24 | $0.00 | $-26.86 | ||
| Q3 24 | $-0.10 | $-0.39 | ||
| Q2 24 | — | $-0.23 | ||
| Q1 24 | $0.14 | $-0.26 | ||
| Q4 23 | $0.00 | $-0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $15.5M | $6.3M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $288.3M | $8.9M |
| 总资产 | $734.9M | $11.0M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BIOXNITO
| Q3 25 | $15.5M | $6.3M | ||
| Q2 25 | — | $3.4M | ||
| Q1 25 | $38.5M | $3.0M | ||
| Q4 24 | $29.2M | $2.2M | ||
| Q3 24 | $32.3M | $2.7M | ||
| Q2 24 | — | $4.5M | ||
| Q1 24 | $16.4M | $3.5M | ||
| Q4 23 | $24.4M | $4.4M |
股东权益BIOXNITO
| Q3 25 | $288.3M | $8.9M | ||
| Q2 25 | — | $5.8M | ||
| Q1 25 | $345.0M | $3.9M | ||
| Q4 24 | $346.3M | $4.7M | ||
| Q3 24 | $346.0M | $5.4M | ||
| Q2 24 | — | $6.0M | ||
| Q1 24 | $348.5M | $5.8M | ||
| Q4 23 | $335.3M | $6.5M |
总资产BIOXNITO
| Q3 25 | $734.9M | $11.0M | ||
| Q2 25 | — | $7.8M | ||
| Q1 25 | $798.2M | $7.4M | ||
| Q4 24 | $835.2M | $5.5M | ||
| Q3 24 | $827.3M | $5.8M | ||
| Q2 24 | — | $7.5M | ||
| Q1 24 | $836.1M | $6.3M | ||
| Q4 23 | $819.5M | $7.2M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $14.4M | $-974.0K |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | -2.27× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流BIOXNITO
| Q3 25 | $14.4M | $-974.0K | ||
| Q2 25 | — | $-528.0K | ||
| Q1 25 | $23.3M | $-809.0K | ||
| Q4 24 | $-5.4M | $-492.0K | ||
| Q3 24 | $5.2M | $-891.0K | ||
| Q2 24 | — | $-1.0M | ||
| Q1 24 | $-17.4M | $-1.0M | ||
| Q4 23 | $21.1M | $-975.1K |
现金转化率BIOXNITO
| Q3 25 | — | -2.27× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | -8.85× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -1.78× | — | ||
| Q4 23 | 17.05× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
